Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

REGENXBIO Presents Positive Initial Data from Phase II ALTITUDE™ Trial of RGX-314 for …,

ROCKVILLE, Md., Oct. 9, 2021 /PRNewswire/ –. Suprachoroidal delivery of RGX-314 well tolerated in 15 patients in Cohort 1 with no drug-related serious …, ROCKVILLE, Md., Oct. 9, 2021 /PRNewswire/ –. Suprachoroidal delivery of RGX-314 well tolerated in 15 patients in Cohort 1 with no drug-related serious …, Read More

Scroll to Top